LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS WITH AND WITHOUT PRIOR ANTI-TUMOR NECROSIS FACTOR EXPOSURE: 96-WEEK OUTCOMES OF THE RAPID-PSA TRIAL
Author(s):
Mease, P.J.; Fleischmann, R.; Wollenhaupt, J.; Deodhar, A.; Gladman, D.; Arledge, T.; Peterson, L.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Clinical and Experimental Rheumatology (2014), Vol. 32, no. 5, p. 786-786
